- Home
- BSIN vs MREO Comparison
BSIN vs MREO Comparison
Compare BSIN & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
SELL
HOLD
Current Price
$0.30
Company Overview
Basic Information| Metric | BSIN | MREO |
|---|---|---|
| Founded | 1966 | 2015 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.4M | 50.3M |
| IPO Year | 1995 | 2017 |
Fundamental Metrics
Financial Performance| Metric | BSIN | MREO |
|---|---|---|
| Price | $1.43 | $0.30 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | ★ $2.75 | $1.97 |
| AVG Volume (30 Days) | 509.9K | ★ 1.5M |
| Earning Date | 11-11-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.21 | 16.67 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $32,379,000.00 | $500,000.00 |
| Revenue This Year | $11.55 | N/A |
| Revenue Next Year | $169.70 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.00 | $0.20 |
| 52 Week High | $1.67 | $2.37 |
Technical Indicators
Market Signals| Indicator | BSIN | MREO |
|---|---|---|
| Relative Strength Index (RSI) | 44.44 | 43.39 |
| Support Level | $1.09 | $0.26 |
| Resistance Level | $1.50 | $0.35 |
| Average True Range (ATR) | 0.06 | 0.04 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 20.58 | 2.31 |
Price Performance
Historical Comparison BSIN
MREO
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).